Arcadia Operating Cycle from 2010 to 2026
| RKDA Stock | USD 1.87 0.02 1.06% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 176.73 | Current Value 249.22 | Quarterly Volatility 189.97440904 |
Check Arcadia Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcadia Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 123.5 K, Interest Expense of 247.1 K or Selling General Administrative of 14.4 M, as well as many indicators such as Price To Sales Ratio of 1.75, Dividend Yield of 0.0018 or PTB Ratio of 1.23. Arcadia financial statements analysis is a perfect complement when working with Arcadia Biosciences Valuation or Volatility modules.
Arcadia | Operating Cycle | Build AI portfolio with Arcadia Stock |
Analyzing Arcadia Biosciences's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing Arcadia Biosciences's current valuation and future prospects.
Latest Arcadia Biosciences' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Arcadia Biosciences over the last few years. It is Arcadia Biosciences' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcadia Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Arcadia Operating Cycle Regression Statistics
| Arithmetic Mean | 313.27 | |
| Geometric Mean | 274.98 | |
| Coefficient Of Variation | 60.64 | |
| Mean Deviation | 131.68 | |
| Median | 259.57 | |
| Standard Deviation | 189.97 | |
| Sample Variance | 36,090 | |
| Range | 786 | |
| R-Value | (0.19) | |
| Mean Square Error | 37,155 | |
| R-Squared | 0.03 | |
| Significance | 0.47 | |
| Slope | (7.02) | |
| Total Sum of Squares | 577,444 |
Arcadia Operating Cycle History
About Arcadia Biosciences Financial Statements
Arcadia Biosciences stakeholders use historical fundamental indicators, such as Arcadia Biosciences' Operating Cycle, to determine how well the company is positioned to perform in the future. Although Arcadia Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Arcadia Biosciences' assets and liabilities are reflected in the revenues and expenses on Arcadia Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Arcadia Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 176.73 | 249.22 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:Check out the analysis of Arcadia Biosciences Correlation against competitors. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. Anticipated expansion of Arcadia directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Arcadia Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.285 | Earnings Share (3.69) | Revenue Per Share | Quarterly Revenue Growth (0.15) | Return On Assets |
Understanding Arcadia Biosciences requires distinguishing between market price and book value, where the latter reflects Arcadia's accounting equity. The concept of intrinsic value - what Arcadia Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Arcadia Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Arcadia Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Arcadia Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Arcadia Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.